Findings

What do systematic reviews say?

1,041 questions · 1,056 findings · 283 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 346 · 32.8%GRADE not reported 111 · 10.5%Very low 326 · 30.9%Low 195 · 18.5%Moderate 66 · 6.3%High 12 · 1.1%

High vs low dose pegylated interferon alpha‐2a or alpha‐2b

Serious adverse events · patients on HD with HCV infection

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for dialysis patients with hepatitis C virus (HCV) infection 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Standard interferon plus ribavirin vs standard interferon

Adverse events · patients on HD with HCV infection

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for dialysis patients with hepatitis C virus (HCV) infection 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Pegylated interferon plus ribavirin vs pegylated interferon alone

Adverse events · patients on HD with HCV infection

Pegylated interferon plus ribavirin may leads to higher adverse events compared with pegylated interferon alone (low certainty).

1 finding from 1 review

Interventions for dialysis patients with hepatitis C virus (HCV) infection 2023 · Cochrane Headline outcomes only
RR 1.1 [1.01, 1.19]
1 study · 377 participants
Low

Direct antivirals (grazoprevir and elbasvir) vs placebo

Adverse events · patients on HD with HCV infection

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for dialysis patients with hepatitis C virus (HCV) infection 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Pegylated interferon + ribavirin (24 weeks) + initial telepravir (12 weeks) vs pegylated interferon (48 weeks) + initial telepravir (12 weeks) + initial low dose ribavirin (12 + 36 weeks)

Adverse events · patients on HD with HCV infection

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for dialysis patients with hepatitis C virus (HCV) infection 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Standard interferon vs placebo or control

Adverse events · patients on HD with HCV infection

Standard interferon showed no clear difference in adverse events compared with placebo or control (moderate certainty).

1 finding from 1 review

Interventions for dialysis patients with hepatitis C virus (HCV) infection 2023 · Cochrane Headline outcomes only
RR 3.56 [0.98, 13.01]
5 studies · 143 participants
Moderate

Engagement of community leaders vs usual care

Adverse events · children under 5 years of age

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for improving coverage of childhood immunisation in low‐ and middle‐income countries 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Health education vs usual care

Adverse events · children under 5 years of age

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for improving coverage of childhood immunisation in low‐ and middle‐income countries 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Monetary incentives vs usual care

Adverse events · children under 5 years of age

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for improving coverage of childhood immunisation in low‐ and middle‐income countries 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Digital register vs usual care

Adverse events · children under 5 years of age

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for improving coverage of childhood immunisation in low‐ and middle‐income countries 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Phone call/SMS with/without combination with monetary incentives vs usual care

Adverse events · children under 5 years of age

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for improving coverage of childhood immunisation in low‐ and middle‐income countries 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Wearable reminders vs usual care

Adverse events · children under 5 years of age

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for improving coverage of childhood immunisation in low‐ and middle‐income countries 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Training of health providers vs usual care

Adverse events · children under 5 years of age

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for improving coverage of childhood immunisation in low‐ and middle‐income countries 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Home visit vs usual care

Adverse events · children under 5 years of age

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for improving coverage of childhood immunisation in low‐ and middle‐income countries 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Immunisation outreach vs usual care

Adverse events · children under 5 years of age

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for improving coverage of childhood immunisation in low‐ and middle‐income countries 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Integration of immunisation with other health services vs usual care

Adverse events · children under 5 years of age

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for improving coverage of childhood immunisation in low‐ and middle‐income countries 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Physical activities vs usual care

Adverse events · sleep disturbances in dementia

1 finding from 1 review

Non‐pharmacological interventions for sleep disturbances in people with dementia 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 167 participants
Moderate

Summary of findings table ‐ Social activities vs usual care

Adverse events · sleep disturbances in dementia

1 finding from 1 review

Non‐pharmacological interventions for sleep disturbances in people with dementia 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 236 participants
Low

Summary of findings table ‐ Light therapy vs usual care

Adverse events · sleep disturbances in dementia

1 finding from 1 review

Non‐pharmacological interventions for sleep disturbances in people with dementia 2023 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 318 participants
Very low

Angiotensin‐converting enzyme inhibitors vs vitamin C

Serious adverse events · children with sickle cell anaemia and microalbuminuria

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for chronic kidney disease in people with sickle cell disease 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found